1,301 to 1,310 of 7,037 Results
Jul 28, 2024 - Paul Wen LIU
Liu, Paul Wen, 2024, "Boosting energy efficiency and selectivity of glucose oxidation to glucuronic acid in high frequency ultrasound using multicavity CuO catalytic cavitation agents", https://doi.org/10.21979/N9/FMPRYE, DR-NTU (Data), V1
Research data for the manuscript "Boosting energy efficiency and selectivity of glucose oxidation to glucuronic acid in high frequency ultrasound using multicavity CuO catalytic cavitation agents" |
Jul 3, 2024 - Paul Wen LIU
Liu, Paul Wen, 2024, "An investigation of the structural and electronic origins of enhanced chemical looping air separation performance of B-site substituted SrFe1-xCoxO3-δ perovskites", https://doi.org/10.21979/N9/OGIWAS, DR-NTU (Data), V1
This dataset provides the research data for the manuscript "An investigation of the structural and electronic origins of enhanced chemical looping air separation performance of B-site substituted SrFe1-xCoxO3-δ perovskites". |
ZIP Archive - 156.4 MB -
MD5: 7d09fde09712dd6be590852769b0d346
|
Mar 11, 2024 - ZAN Ping
Zan, Ping; Than, Aung; Leow, Melvin Khee Shing; Cai, Helen Xinyi; Wen, Hanqi; Zhang, Zheye; Chen, Peng, 2024, "Dry powder microneedle-enabled transdermal anti-inflammatory therapy for obesity, diabetes, hyperlipidemia, and fatty liver", https://doi.org/10.21979/N9/GCCTII, DR-NTU (Data), V1
Obese white adipose tissue (WAT) is characterized by hypoxia, oxidative stress, and inflammation, which are the key drivers of various deleterious diseases. Herein, we demonstrate a new strategy to directly induce ameliorative remodeling of obese subcutaneous WAT (sWAT). Manganes... |
Mar 11, 2024 -
Dry powder microneedle-enabled transdermal anti-inflammatory therapy for obesity, diabetes, hyperlipidemia, and fatty liver
JPEG Image - 3.9 MB -
MD5: b463b08acfc110b088e8887096d3b73c
|
Mar 11, 2024 -
Dry powder microneedle-enabled transdermal anti-inflammatory therapy for obesity, diabetes, hyperlipidemia, and fatty liver
JPEG Image - 881.9 KB -
MD5: e33c93290a91cda569908e9931f64bd7
|
Mar 11, 2024 -
Dry powder microneedle-enabled transdermal anti-inflammatory therapy for obesity, diabetes, hyperlipidemia, and fatty liver
JPEG Image - 532.9 KB -
MD5: c0d9ed30518739ce1c61dcb8b1beb70b
|
Mar 11, 2024 -
Dry powder microneedle-enabled transdermal anti-inflammatory therapy for obesity, diabetes, hyperlipidemia, and fatty liver
JPEG Image - 505.4 KB -
MD5: 9bab26996c322a2f5b5d9b98b2e83e74
|
Mar 11, 2024 -
Dry powder microneedle-enabled transdermal anti-inflammatory therapy for obesity, diabetes, hyperlipidemia, and fatty liver
JPEG Image - 7.8 MB -
MD5: 646a42630fadd8a75c628307959f07bc
|
Mar 11, 2024 -
Dry powder microneedle-enabled transdermal anti-inflammatory therapy for obesity, diabetes, hyperlipidemia, and fatty liver
PNG Image - 9.1 MB -
MD5: f7bdc1140f61de6073fde7c0b209e59c
|
